Literature DB >> 11756425

Specificity determining residues in ammonia- and glutamine-dependent carbamoyl phosphate synthetases.

Amna Saeed-Kothe1, Susan G Powers-Lee.   

Abstract

Carbamoyl phosphate synthetases (CPSs) utilize either glutamine or ammonia for the ATP-dependent generation of carbamoyl phosphate. In glutamine-utilizing CPSs (e.g. the single Escherichia coli CPS and mammalian CPS II), the hydrolysis of glutamine to yield ammonia is catalyzed at a triad-type glutamine amidotransferase domain. Non-glutamine-utilizing CPSs (e.g. rat and human CPS I), lacking the catalytic cysteine residue, can generate carbamoyl phosphate only in the presence of free ammonia. Frog CPS I (fCPS I), unlike mammalian CPS Is, retains most of the glutamine amidotransferase residues conserved in glutamine-utilizing CPSs, including an intact catalytic triad, and could therefore be expected to use glutamine. Our work with native fCPS I provides the first demonstration of the inability of this enzyme to bind/utilize glutamine. To determine why fCPS I is unable to utilize glutamine, we compared sequences of glutamine-using and non-glutamine-using CPSs to identify residues that are present or conservatively substituted in all glutamine-utilizing CPSs but absent in fCPS I. We constructed the site-directed mutants Q273E, L270K, Q273E/N240S, and Q273E/L270K in E. coli CPS and have determined that simultaneous occurrence of the two substitutions, Gln-->Glu and Leu-->Lys, found in the frog CPS I glutamine amidotransferase domain are sufficient to eliminate glutamine utilization by the E. coli enzyme.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11756425     DOI: 10.1074/jbc.M110926200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Nucleotide recognition in the ATP-grasp protein carbamoyl phosphate synthetase.

Authors:  Michael Kothe; Susan G Powers-Lee
Journal:  Protein Sci       Date:  2004-01-10       Impact factor: 6.725

2.  Hepatic carbamoyl phosphate synthetase (CPS) I and urea contents in the hylid tree frog, Litoria caerulea: transition from CPS III to CPS I.

Authors:  Yuen K Ip; Ai M Loong; You R Chng; Kum C Hiong; Shit F Chew
Journal:  J Comp Physiol B       Date:  2012-06-27       Impact factor: 2.200

3.  Molecular characterization and mRNA expression of carbamoyl phosphate synthetase III in the liver of the African lungfish, Protopterus annectens, during aestivation or exposure to ammonia.

Authors:  A M Loong; Y R Chng; S F Chew; W P Wong; Y K Ip
Journal:  J Comp Physiol B       Date:  2011-10-30       Impact factor: 2.200

4.  Enhanced production of L-arginine by improving carbamoyl phosphate supply in metabolically engineered Corynebacterium crenatum.

Authors:  Qing Wang; An Jiang; Jiabing Tang; Hui Gao; Xian Zhang; Taowei Yang; Zhenghong Xu; Meijuan Xu; Zhiming Rao
Journal:  Appl Microbiol Biotechnol       Date:  2021-04-10       Impact factor: 4.813

5.  Human carbamoyl-phosphate synthetase: insight into N-acetylglutamate interaction and the functional effects of a common single nucleotide polymorphism.

Authors:  V Ahuja; S G Powers-Lee
Journal:  J Inherit Metab Dis       Date:  2008-08-09       Impact factor: 4.982

6.  Role of Cys-1327 and Cys-1337 in redox sensitivity and allosteric monitoring in human carbamoyl phosphate synthetase.

Authors:  Emily J Hart; Susan G Powers-Lee
Journal:  J Biol Chem       Date:  2008-12-23       Impact factor: 5.157

7.  3-isobutylmethylxanthine inhibits hepatic urea synthesis: protection by agmatine.

Authors:  Itzhak Nissim; Oksana Horyn; Ilana Nissim; Yevgeny Daikhin; Suzanne L Wehrli; Marc Yudkoff
Journal:  J Biol Chem       Date:  2008-03-28       Impact factor: 5.157

8.  Inversion of allosteric effect of arginine on N-acetylglutamate synthase, a molecular marker for evolution of tetrapods.

Authors:  Nantaporn Haskins; Maria Panglao; Qiuhao Qu; Himani Majumdar; Juan Cabrera-Luque; Hiroki Morizono; Mendel Tuchman; Ljubica Caldovic
Journal:  BMC Biochem       Date:  2008-09-18       Impact factor: 4.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.